T. Rowe Price New Horizons Fund, Inc. VRDN Holdings History
T. Rowe Price New Horizons Fund, Inc.'s Viridian Therapeutics Inc Holding Summary
As of 2025-03-31, T. Rowe Price New Horizons Fund, Inc. held 972,508.00 shares of Viridian Therapeutics Inc(VRDN), totaling $13.11 Mil. This investment constitutes 0.08% of their stock portfolio, and T. Rowe Price New Horizons Fund, Inc. now holds 1.19% of the outstanding Viridian Therapeutics Inc(VRDN) stock.
The initial trade took place in 2024Q4. And since then T. Rowe Price New Horizons Fund, Inc. has made 2 purchases of VRDN, at an average price of $17.09, for a total of 45.99 Mil shares. Based on historical transaction data and VRDN's current price of $16.52, T. Rowe Price New Horizons Fund, Inc.'s estimated gain on his VRDN holdings is $-26.36 Mil, reflecting a -3.35% gain to date.
T. Rowe Price New Horizons Fund, Inc. VRDN ($16.52) Holding Chart
T. Rowe Price New Horizons Fund, Inc. VRDN ($16.52) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1